β-glucans from Coriolus versicolor protect mice against S. typhimurium challenge by activation of macrophages

•There are no detectable cytotoxic effects of β-glucans.•β-glucans induce strong proliferaion and expresion of CD40, CD80, and CD86 marker of macrophages.•β-glucans-treated macrophage but not itself can phagocytize and kill S. typhimurium.•β-glucans induce the production of NO and iNOS from pretreat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of biological macromolecules 2016-05, Vol.86, p.352-361
Hauptverfasser: Shi, Shao-Hua, Yang, Wen-Tao, Huang, Ke-Yan, Jiang, Yan-Long, Yang, Gui-Lian, Wang, Chun-Feng, Li, Yu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 361
container_issue
container_start_page 352
container_title International journal of biological macromolecules
container_volume 86
creator Shi, Shao-Hua
Yang, Wen-Tao
Huang, Ke-Yan
Jiang, Yan-Long
Yang, Gui-Lian
Wang, Chun-Feng
Li, Yu
description •There are no detectable cytotoxic effects of β-glucans.•β-glucans induce strong proliferaion and expresion of CD40, CD80, and CD86 marker of macrophages.•β-glucans-treated macrophage but not itself can phagocytize and kill S. typhimurium.•β-glucans induce the production of NO and iNOS from pretreated macrophages.•β-glucans-treated macrophages are effective at protecting mice against the challenge of S. typhimurium. The effects of β-glucans from Coriolus versicolor (CVP), which are extracted from a well-known immune stimulator C. versicolor, have been demonstrated extensively in vitro and in vivo. However, until now, the phagocytic activity has not been elucidated. Hence, the objective of the present study was to identify the antibacterial activity of CVP or CVP-treated macrophages by an analysis of cell cytotoxicity, phagocytic activity, intracellular bacterial survival, macrophage activation, production of nitric oxide (NO) and expression of inducible nitric oxide synthase (iNOS) in CVP-treated macrophages using flow cytometry, RT-PCR, a gentamicin protection assay, a Nitric oxide assay and an iNOS enzymatic activity assay. The results indicate that CVP-treated macrophages can phagocytize and kill bacteria, probably due to the production of NO and iNOS. More importantly, CVP-treated macrophages are effective at protecting mice against the challenge of Salmonella typhimurium. The results of this study suggest that the antibacterial effects of CVP are probably caused by the activation of innate immune cells, especially macrophages, because the activated macrophage produces NO, which kills bacteria. These phenomena indicate the possibility of CVP as a potential alternative for antibiotics against resistant bacteria.
doi_str_mv 10.1016/j.ijbiomac.2016.01.058
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1776093351</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0141813016300605</els_id><sourcerecordid>1776093351</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-376de6a85e9b99c7ef3121f23ad49e7cbcc5dae1fbb967ba00879e60b1d9f5333</originalsourceid><addsrcrecordid>eNqFkE1OwzAQhS0EoqVwhcpLNgmeuHGSHajiT0JiAawt25m0rpK42EmlXouDcCaMCmxZjWb0Zua9j5A5sBQYiKtNajfauk6ZNIt9yiBleXlEplAWVcIY48dkymABSQmcTchZCJs4FTmUp2SSiZJl2WIxJf3nR7JqR6P6QBvvOrp03rp2DHSHPljjWufp1rsBzUA7a5CqlbJ9GOhLSof9dm270duxo2at2hb7FVK9p8oMdqcG63rqGhpNerddqxWGc3LSqDbgxU-dkbe729flQ_L0fP-4vHlKDBflkPBC1ChUmWOlq8oU2HDIoMm4qhcVFkYbk9cKodG6EoVWjMXUKJiGumpyzvmMXB7uRuvvI4ZBdjYYbFvVoxuDhKIQrOI8hygVB2k0GYLHRm697ZTfS2Dym7XcyF_W8pu1ZCAj67g4__kx6g7rv7VfuFFwfRBgTLqz6GUwFnuDtfURp6yd_e_HF-W7lsc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1776093351</pqid></control><display><type>article</type><title>β-glucans from Coriolus versicolor protect mice against S. typhimurium challenge by activation of macrophages</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Shi, Shao-Hua ; Yang, Wen-Tao ; Huang, Ke-Yan ; Jiang, Yan-Long ; Yang, Gui-Lian ; Wang, Chun-Feng ; Li, Yu</creator><creatorcontrib>Shi, Shao-Hua ; Yang, Wen-Tao ; Huang, Ke-Yan ; Jiang, Yan-Long ; Yang, Gui-Lian ; Wang, Chun-Feng ; Li, Yu</creatorcontrib><description>•There are no detectable cytotoxic effects of β-glucans.•β-glucans induce strong proliferaion and expresion of CD40, CD80, and CD86 marker of macrophages.•β-glucans-treated macrophage but not itself can phagocytize and kill S. typhimurium.•β-glucans induce the production of NO and iNOS from pretreated macrophages.•β-glucans-treated macrophages are effective at protecting mice against the challenge of S. typhimurium. The effects of β-glucans from Coriolus versicolor (CVP), which are extracted from a well-known immune stimulator C. versicolor, have been demonstrated extensively in vitro and in vivo. However, until now, the phagocytic activity has not been elucidated. Hence, the objective of the present study was to identify the antibacterial activity of CVP or CVP-treated macrophages by an analysis of cell cytotoxicity, phagocytic activity, intracellular bacterial survival, macrophage activation, production of nitric oxide (NO) and expression of inducible nitric oxide synthase (iNOS) in CVP-treated macrophages using flow cytometry, RT-PCR, a gentamicin protection assay, a Nitric oxide assay and an iNOS enzymatic activity assay. The results indicate that CVP-treated macrophages can phagocytize and kill bacteria, probably due to the production of NO and iNOS. More importantly, CVP-treated macrophages are effective at protecting mice against the challenge of Salmonella typhimurium. The results of this study suggest that the antibacterial effects of CVP are probably caused by the activation of innate immune cells, especially macrophages, because the activated macrophage produces NO, which kills bacteria. These phenomena indicate the possibility of CVP as a potential alternative for antibiotics against resistant bacteria.</description><identifier>ISSN: 0141-8130</identifier><identifier>EISSN: 1879-0003</identifier><identifier>DOI: 10.1016/j.ijbiomac.2016.01.058</identifier><identifier>PMID: 26802244</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adjuvants, Immunologic - isolation &amp; purification ; Adjuvants, Immunologic - pharmacology ; Animals ; Antibacterial activities ; beta-Glucans - isolation &amp; purification ; beta-Glucans - pharmacology ; Body Weight - drug effects ; Coriolus versicolor ; Female ; Gene Expression Regulation, Enzymologic - drug effects ; Intracellular Space - drug effects ; Intracellular Space - microbiology ; Macrophage Activation - drug effects ; Macrophages ; Macrophages - cytology ; Macrophages - drug effects ; Macrophages - immunology ; Macrophages - metabolism ; Mice ; Nitric Oxide - biosynthesis ; Nitric Oxide Synthase Type II - genetics ; Nitric Oxide Synthase Type II - metabolism ; Phagocytosis - drug effects ; Polyporaceae - chemistry ; RAW 264.7 Cells ; Salmonella typhimurium ; Salmonella typhimurium - drug effects ; Salmonella typhimurium - growth &amp; development ; Salmonella typhimurium - physiology ; β-glucans</subject><ispartof>International journal of biological macromolecules, 2016-05, Vol.86, p.352-361</ispartof><rights>2016 Elsevier B.V.</rights><rights>Copyright © 2016 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-376de6a85e9b99c7ef3121f23ad49e7cbcc5dae1fbb967ba00879e60b1d9f5333</citedby><cites>FETCH-LOGICAL-c368t-376de6a85e9b99c7ef3121f23ad49e7cbcc5dae1fbb967ba00879e60b1d9f5333</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0141813016300605$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26802244$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shi, Shao-Hua</creatorcontrib><creatorcontrib>Yang, Wen-Tao</creatorcontrib><creatorcontrib>Huang, Ke-Yan</creatorcontrib><creatorcontrib>Jiang, Yan-Long</creatorcontrib><creatorcontrib>Yang, Gui-Lian</creatorcontrib><creatorcontrib>Wang, Chun-Feng</creatorcontrib><creatorcontrib>Li, Yu</creatorcontrib><title>β-glucans from Coriolus versicolor protect mice against S. typhimurium challenge by activation of macrophages</title><title>International journal of biological macromolecules</title><addtitle>Int J Biol Macromol</addtitle><description>•There are no detectable cytotoxic effects of β-glucans.•β-glucans induce strong proliferaion and expresion of CD40, CD80, and CD86 marker of macrophages.•β-glucans-treated macrophage but not itself can phagocytize and kill S. typhimurium.•β-glucans induce the production of NO and iNOS from pretreated macrophages.•β-glucans-treated macrophages are effective at protecting mice against the challenge of S. typhimurium. The effects of β-glucans from Coriolus versicolor (CVP), which are extracted from a well-known immune stimulator C. versicolor, have been demonstrated extensively in vitro and in vivo. However, until now, the phagocytic activity has not been elucidated. Hence, the objective of the present study was to identify the antibacterial activity of CVP or CVP-treated macrophages by an analysis of cell cytotoxicity, phagocytic activity, intracellular bacterial survival, macrophage activation, production of nitric oxide (NO) and expression of inducible nitric oxide synthase (iNOS) in CVP-treated macrophages using flow cytometry, RT-PCR, a gentamicin protection assay, a Nitric oxide assay and an iNOS enzymatic activity assay. The results indicate that CVP-treated macrophages can phagocytize and kill bacteria, probably due to the production of NO and iNOS. More importantly, CVP-treated macrophages are effective at protecting mice against the challenge of Salmonella typhimurium. The results of this study suggest that the antibacterial effects of CVP are probably caused by the activation of innate immune cells, especially macrophages, because the activated macrophage produces NO, which kills bacteria. These phenomena indicate the possibility of CVP as a potential alternative for antibiotics against resistant bacteria.</description><subject>Adjuvants, Immunologic - isolation &amp; purification</subject><subject>Adjuvants, Immunologic - pharmacology</subject><subject>Animals</subject><subject>Antibacterial activities</subject><subject>beta-Glucans - isolation &amp; purification</subject><subject>beta-Glucans - pharmacology</subject><subject>Body Weight - drug effects</subject><subject>Coriolus versicolor</subject><subject>Female</subject><subject>Gene Expression Regulation, Enzymologic - drug effects</subject><subject>Intracellular Space - drug effects</subject><subject>Intracellular Space - microbiology</subject><subject>Macrophage Activation - drug effects</subject><subject>Macrophages</subject><subject>Macrophages - cytology</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - immunology</subject><subject>Macrophages - metabolism</subject><subject>Mice</subject><subject>Nitric Oxide - biosynthesis</subject><subject>Nitric Oxide Synthase Type II - genetics</subject><subject>Nitric Oxide Synthase Type II - metabolism</subject><subject>Phagocytosis - drug effects</subject><subject>Polyporaceae - chemistry</subject><subject>RAW 264.7 Cells</subject><subject>Salmonella typhimurium</subject><subject>Salmonella typhimurium - drug effects</subject><subject>Salmonella typhimurium - growth &amp; development</subject><subject>Salmonella typhimurium - physiology</subject><subject>β-glucans</subject><issn>0141-8130</issn><issn>1879-0003</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1OwzAQhS0EoqVwhcpLNgmeuHGSHajiT0JiAawt25m0rpK42EmlXouDcCaMCmxZjWb0Zua9j5A5sBQYiKtNajfauk6ZNIt9yiBleXlEplAWVcIY48dkymABSQmcTchZCJs4FTmUp2SSiZJl2WIxJf3nR7JqR6P6QBvvOrp03rp2DHSHPljjWufp1rsBzUA7a5CqlbJ9GOhLSof9dm270duxo2at2hb7FVK9p8oMdqcG63rqGhpNerddqxWGc3LSqDbgxU-dkbe729flQ_L0fP-4vHlKDBflkPBC1ChUmWOlq8oU2HDIoMm4qhcVFkYbk9cKodG6EoVWjMXUKJiGumpyzvmMXB7uRuvvI4ZBdjYYbFvVoxuDhKIQrOI8hygVB2k0GYLHRm697ZTfS2Dym7XcyF_W8pu1ZCAj67g4__kx6g7rv7VfuFFwfRBgTLqz6GUwFnuDtfURp6yd_e_HF-W7lsc</recordid><startdate>201605</startdate><enddate>201605</enddate><creator>Shi, Shao-Hua</creator><creator>Yang, Wen-Tao</creator><creator>Huang, Ke-Yan</creator><creator>Jiang, Yan-Long</creator><creator>Yang, Gui-Lian</creator><creator>Wang, Chun-Feng</creator><creator>Li, Yu</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201605</creationdate><title>β-glucans from Coriolus versicolor protect mice against S. typhimurium challenge by activation of macrophages</title><author>Shi, Shao-Hua ; Yang, Wen-Tao ; Huang, Ke-Yan ; Jiang, Yan-Long ; Yang, Gui-Lian ; Wang, Chun-Feng ; Li, Yu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-376de6a85e9b99c7ef3121f23ad49e7cbcc5dae1fbb967ba00879e60b1d9f5333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adjuvants, Immunologic - isolation &amp; purification</topic><topic>Adjuvants, Immunologic - pharmacology</topic><topic>Animals</topic><topic>Antibacterial activities</topic><topic>beta-Glucans - isolation &amp; purification</topic><topic>beta-Glucans - pharmacology</topic><topic>Body Weight - drug effects</topic><topic>Coriolus versicolor</topic><topic>Female</topic><topic>Gene Expression Regulation, Enzymologic - drug effects</topic><topic>Intracellular Space - drug effects</topic><topic>Intracellular Space - microbiology</topic><topic>Macrophage Activation - drug effects</topic><topic>Macrophages</topic><topic>Macrophages - cytology</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - immunology</topic><topic>Macrophages - metabolism</topic><topic>Mice</topic><topic>Nitric Oxide - biosynthesis</topic><topic>Nitric Oxide Synthase Type II - genetics</topic><topic>Nitric Oxide Synthase Type II - metabolism</topic><topic>Phagocytosis - drug effects</topic><topic>Polyporaceae - chemistry</topic><topic>RAW 264.7 Cells</topic><topic>Salmonella typhimurium</topic><topic>Salmonella typhimurium - drug effects</topic><topic>Salmonella typhimurium - growth &amp; development</topic><topic>Salmonella typhimurium - physiology</topic><topic>β-glucans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shi, Shao-Hua</creatorcontrib><creatorcontrib>Yang, Wen-Tao</creatorcontrib><creatorcontrib>Huang, Ke-Yan</creatorcontrib><creatorcontrib>Jiang, Yan-Long</creatorcontrib><creatorcontrib>Yang, Gui-Lian</creatorcontrib><creatorcontrib>Wang, Chun-Feng</creatorcontrib><creatorcontrib>Li, Yu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of biological macromolecules</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shi, Shao-Hua</au><au>Yang, Wen-Tao</au><au>Huang, Ke-Yan</au><au>Jiang, Yan-Long</au><au>Yang, Gui-Lian</au><au>Wang, Chun-Feng</au><au>Li, Yu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>β-glucans from Coriolus versicolor protect mice against S. typhimurium challenge by activation of macrophages</atitle><jtitle>International journal of biological macromolecules</jtitle><addtitle>Int J Biol Macromol</addtitle><date>2016-05</date><risdate>2016</risdate><volume>86</volume><spage>352</spage><epage>361</epage><pages>352-361</pages><issn>0141-8130</issn><eissn>1879-0003</eissn><abstract>•There are no detectable cytotoxic effects of β-glucans.•β-glucans induce strong proliferaion and expresion of CD40, CD80, and CD86 marker of macrophages.•β-glucans-treated macrophage but not itself can phagocytize and kill S. typhimurium.•β-glucans induce the production of NO and iNOS from pretreated macrophages.•β-glucans-treated macrophages are effective at protecting mice against the challenge of S. typhimurium. The effects of β-glucans from Coriolus versicolor (CVP), which are extracted from a well-known immune stimulator C. versicolor, have been demonstrated extensively in vitro and in vivo. However, until now, the phagocytic activity has not been elucidated. Hence, the objective of the present study was to identify the antibacterial activity of CVP or CVP-treated macrophages by an analysis of cell cytotoxicity, phagocytic activity, intracellular bacterial survival, macrophage activation, production of nitric oxide (NO) and expression of inducible nitric oxide synthase (iNOS) in CVP-treated macrophages using flow cytometry, RT-PCR, a gentamicin protection assay, a Nitric oxide assay and an iNOS enzymatic activity assay. The results indicate that CVP-treated macrophages can phagocytize and kill bacteria, probably due to the production of NO and iNOS. More importantly, CVP-treated macrophages are effective at protecting mice against the challenge of Salmonella typhimurium. The results of this study suggest that the antibacterial effects of CVP are probably caused by the activation of innate immune cells, especially macrophages, because the activated macrophage produces NO, which kills bacteria. These phenomena indicate the possibility of CVP as a potential alternative for antibiotics against resistant bacteria.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>26802244</pmid><doi>10.1016/j.ijbiomac.2016.01.058</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0141-8130
ispartof International journal of biological macromolecules, 2016-05, Vol.86, p.352-361
issn 0141-8130
1879-0003
language eng
recordid cdi_proquest_miscellaneous_1776093351
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adjuvants, Immunologic - isolation & purification
Adjuvants, Immunologic - pharmacology
Animals
Antibacterial activities
beta-Glucans - isolation & purification
beta-Glucans - pharmacology
Body Weight - drug effects
Coriolus versicolor
Female
Gene Expression Regulation, Enzymologic - drug effects
Intracellular Space - drug effects
Intracellular Space - microbiology
Macrophage Activation - drug effects
Macrophages
Macrophages - cytology
Macrophages - drug effects
Macrophages - immunology
Macrophages - metabolism
Mice
Nitric Oxide - biosynthesis
Nitric Oxide Synthase Type II - genetics
Nitric Oxide Synthase Type II - metabolism
Phagocytosis - drug effects
Polyporaceae - chemistry
RAW 264.7 Cells
Salmonella typhimurium
Salmonella typhimurium - drug effects
Salmonella typhimurium - growth & development
Salmonella typhimurium - physiology
β-glucans
title β-glucans from Coriolus versicolor protect mice against S. typhimurium challenge by activation of macrophages
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T15%3A58%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%CE%B2-glucans%20from%20Coriolus%20versicolor%20protect%20mice%20against%20S.%20typhimurium%20challenge%20by%20activation%20of%20macrophages&rft.jtitle=International%20journal%20of%20biological%20macromolecules&rft.au=Shi,%20Shao-Hua&rft.date=2016-05&rft.volume=86&rft.spage=352&rft.epage=361&rft.pages=352-361&rft.issn=0141-8130&rft.eissn=1879-0003&rft_id=info:doi/10.1016/j.ijbiomac.2016.01.058&rft_dat=%3Cproquest_cross%3E1776093351%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1776093351&rft_id=info:pmid/26802244&rft_els_id=S0141813016300605&rfr_iscdi=true